Epidemiological Evidence Investigating Transmissible Infection
An extensive amount of recent research has supported the presence of MAP in several potential routes of human exposure. Both viable MAP and MAP DNA have been detected in milk (Boulais et al., 2011; Okura et al., 2012)
Table 3.2.
Cons. Arguments against the potential aetiological role of Mycobacterium avium subsp. paratuberculosis (MAP) in Crohn's disease. Based on Sartor, 2005.| Arguments | Responses from emerging data | References |
| 1. Difference in clinical and pathological responses in paratuberculosis and Crohn's diseases | Confirmed | Momotani et al., 2012; Zarei-Kordshouli et al., 2019 |
| 2. Lack of epidemiological support of transmissible infection | Unresolved | Pierce, 2009; Pierce et al., 2011; Pistone et al., 2012; Opstelten et al., 2016 |
| 3. No evidence of transmission to humans in contact with animals infected with MAP | Unresolved | Qual et al., 2010; Singh et al., 2011a |
| 4. Genotypes of Crohn's disease and bovine MAP isolates not similar | Refuted | Paustian et al., 2008; Singh et al., 2009; Bannantine et al., 2014; Wynne et al., 2011; Timms et al., 2015 |
| 5. Variability in detection of MAP by PCR (0-100% in Crohn's disease and ulcerative colitis tissues) and serological testing | Confirmed | Waddell et al, 2015 |
| 6. No evidence of mycobacterial cell wall by histochemical staining | Unresolved | Jeyanathan et al., 2007; Banche et al., 2015; Zarei-Kordshouli et al., 2019 |
| 7. No worsening of Crohn's disease with immunosuppressive agents or HIV infection | Unresolved | Allen et al, 2011 |
| 8. No documented cell mediated immune responses to MAP in patients with Crohn's disease | Refuted | Sibartie et al., 2010; Olsen et al., 2009, 2013 |
| 9. No therapeutic response to traditional antimycobacterial antibiotics | Unresolved | Selby et al., 2007; Behr and Hanley, 2008; RedHill Biopharma, 2018a, b |
MAP, Mycobacterium avium subsp. paratuberculosis; PCR, polymerase chain reaction.
including in commercially available milk (Carvalho et al., 2012; Gerrard et al., 2018) revealing the ability of this pathogen to withstand pasteurization. MAP has also been detected in meat (Lorencova et al., 2019), cheese (Botsaris et al., 2010; Faria et al., 2014), infant formula (Botsaris et al., 2016; Acharya et al., 2017), water sources (Beumer et al., 2010; Rhodes et al., 2013; Espeschit et al., 2018) and aerosols (Rhodes et al., 2014). From these data, it can be agreed upon that there are numerous opportunities for humans to be exposed to MAP. Yet the ability to detect MAP in the environment does not provide direct evidence of transmission of bacteria into humans, nor does it demonstrate that the burden in these sources exceeds the unknown infectious dose for humans.
A 2009 report described three individuals who developed Crohn's disease that lived in close proximity to one another but otherwise had no recorded contact. The author hypothesized that exposure may have occurred due to a shared water system (Pierce, 2009). Another study published by the same author described seven unrelated children who developed Crohn's disease after moving to Forest, Virginia, where the number of cases of IBD was 47 times more than expected. Of these seven individuals, five (71.4%) were positive for MAP-specific antibodies (anti-p35 and anti-p36) (Pierce et al., 2011).
MAP infection was suggested to have occurred due to contaminated water from nearby dairy farms. Although MAP has been reported in drinking water, neither of these studies investigated whether MAP was present in the water system of the patients' homes. In contrast to these results, a questionnaire-based assessment of the risk of IBD development and milk consumption in over 400,000 participants found that those consuming more milk were at a significantly reduced risk for development of Crohn's disease (Opstelten et al., 2016). Again however, the presence of MAP was not evaluated in this study. One study, which did measure MAP presence in both patients and the potential source of exposure, was conducted in a region of Italy where MAP is endemic in cattle. The authors found MAP DNA in 23/35 (65.7%) biopsies from patients with Crohn's disease and in the circulating tap water (Pistone et al., 2012). It is important to note that MAP was detected in 7/35 (20%) controls in this study. Although the detection of MAP was significantly greater in patients with Crohn's disease, these findings reinforce that exposure is not sufficient to cause disease.An argument raised in regard to the epidemiology of the disease is that there is no evidence of an increased risk to developing Crohn's disease associated with persons in contact with MAP-infected animals such as farmers or veterinarians (Jones et al., 2006). Since the previous edition, there have been few published studies that have addressed this argument. A 2010 cross-sectional survey of 1476 cattle farmers and veterinarians found no relationship between Crohn's disease and MAP exposure (Qual et al.,
2010), although there were only seven cases of Crohn's disease recorded in total. In contrast, a study conducted on 58 animal attendants with reported gastrointestinal problems cultured more MAP compared with controls (Singh et al., 2011a). These data suggest a role of additional confounding factors such as location or the type of livestock.
Additional research is required in order to gain a clearer picture of the epidemiology surrounding the link between MAP and Crohn's disease. But there are several circumstances concerning these types of studies that should be considered. First, research aimed at associating exposure to MAP (today) with presentation of disease (later) is impeded by the unknown incubation period; in cattle bacteria typically persist undetected in a subclinical state for 2-5 years before disease manifests (United States Department of Agriculture, 2008). Therefore, studies starting with ascertained MAP exposure may fail to link cases, which present years later; conversely, studies starting with Crohn's disease cases are unable to do microbial analysis of the environment to which one was exposed in the preceding years. Second, the idea that contact with infected animals must lead to an increased risk in development of the disease is not found with other bacteria whose aetiological role is accepted. For example, cattle are the known reservoirs for E. coli O157:H7, however no increased risk was associated with disease development in those in direct contact with infected cattle (Rangel et al., 2005). Third, Crohn's disease development is thought to involve a combination of factors including genetic susceptibility and immune dysregulation. If MAP only plays a pathogenic role in such susceptible hosts, the vast majority of those exposed would not develop disease. Future research aimed at rigorously evaluating this argument must be long-term and evaluate both bacteriological exposure and host predisposition.
3.4
More on the topic Epidemiological Evidence Investigating Transmissible Infection:
- Hamster Polyoma Virus Infection: Transmissible Lymphoma
- Lawsonia intracellularis Infection: Proliferative Ileitis, Transmissible Ileal Hyperplasia
- Intensive epidemiological studies of HIV infection have shown that it is not transmitted in the community by casual or intimate non-sexual contact.
- EVIDENCE FOR AN INFLUENCE OF APOPTOSIS IN DISEASE PROGRESSION IN LENTIVIRUS INFECTION
- CHAPTER 43 TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
- Epidemiological aspects
- Investigating the Investigated
- In this chapter, we shall be investigating the interaction of metaphysical modalities with vagueness.
- Limitations and Opportunities for the Use of Molecular Epidemiological Tools in Africa
- Agent-Based Simulation for Investigating Genetic and Cultural Transmission
- Coronavirus Infection: Mouse Hepatitis Virus Infection
- Picornavirus Infection: Mouse Encephalomyelitis Virus Infection
- Arenavirus Infection: Lymphocytic Choriomeningitis Virus Infection
- Arterivirus Infection: Lactate Dehydrogenase-Elevating Virus Infection
- Streptococcus pneumoniae Infection: Pneumococcal or Diplococcal Infection
- Updating on Vague Evidence